Dudum is still the largest individual holder of Hims & Hers’ stock, with the latest Form 4 showing that he owned 8 million ...

We recently published 10 Stocks That Vanished in Value Hims & Hers Health, Inc. (NYSE:HIMS) is one of the worst-performing stocks on Tuesday. Shares of telehealth company Hims & Hers Health dropped by ...

HIMS records subscriber surge and revenue growth in second-quarter 2025, but rising costs strain gross margins.

While Wall Street analysts remain cautious on Hims & Hers Health (HIMS), TipRanks’ A.I. Stock Analysis tool shows strong ...

Doctors report insurance cuts are forcing many U.S. patients on Wegovy and Zepbound to pay high out-of-pocket costs.

Current health news highlights include UK investor backing in Assura's acquisition by PHP, Novo Nordisk's legal affairs over Wegovy drug sales, and Apollo Hospitals' increased AI investments. The CDC ...

In Q2 2025, Hims & Hers reported adjusted earnings of $0.17 per share, topping estimates of $0.15. Revenue rose 73% year-over ...

In a Georgia courtroom that could’ve easily been heavy with nothing but pain and anger, widow Regina Johnson shocked ...

May 31, 2021. China's vast manufacturing sector grew at the fastest pace in eight months in May, blowing past e ...

European shares hit a near two-week high on Wednesday, but weak earnings and a costly trade deal with the U.S. has some investors worried about any future gains. Benedicte Lowe from BNP Paribas told ...